Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer

British Journal of Radiology

Volumn 84, Issue 997, 2011, Pages 19-30

  Shin, H J ^a   Kim, H H ^a   Huh, M O ^a   Kim, M J ^a   Yi, A ^a   Kim, H ^a   Son, B H ^b   Ahn, S H ^b  

^a Research Institute of Radiology   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; CALCIFICATION; CANCER INVASION; CORRELATION FUNCTION; ECHOMAMMOGRAPHY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METASTASIS; PATHOLOGY; PREDICTOR VARIABLE; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALCINOSIS; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; YOUNG ADULT;

EID: 78650669573     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/92960562     Document Type: Article

References (35)

1. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
2. Sundquist M, Thorstenson S, Brudin L, Nordenskjold B. Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group. Breast Cancer Res Treat 1999;53:1-8.
3. Elston C, Ellis I. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
4. Neville A, Bettelheim R, Gelber R, Save-Soderbergh J, Davis B, Reed R, et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992;10:696-705.
5. Nasser I, Lee A, Bosari S, Saganich R, Heatley G, Silverman M. Occult axillary lymph node metastases in "nodenegative" breast carcinoma. Hum Pathol 1993;24:950-7.
6. Blamey R, Ellis I, Pinder S, Lee A, Macmillan R, Morgan D, et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990- 1999. Eur J Cancer 2007;43:1548-55.
7. Balslev I, Axelsson C, Zedeler K, Rasmussen B, Carstensen B, Mouridsen H. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 1994;32:281-90.
8. Volpi A, De PF, Nanni O, Granato A, Bajorko P, Becciolini A, et al. Prognostic significance of biologic markers in nodenegative breast cancer patients: a prospective study. Breast Cancer Res Treat 2000;63:181-92.
9. Hery M, Delozier T, Ramaioli A, Julien J, de Lafontan B, Petit T, et al. Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse? Breast 2002;11:442-8.
10. Lauria R, Perrone F, Carlomagno C, De Laurentiis M, Morabito A, Gallo C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 1995;76:1772-8.
11. Lee A, Pinder S, Macmillan R, Mitchell M, Ellis I, Elston C, et al. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 2006;42:357-62.
12. Sundquist M, Thorstenson S, Klintenberg C, Brudin L, Nordenskjold B. Indicators of loco-regional recurrence in breast cancer. The South East Swedish Breast Cancer Group. Eur J Surg Oncol 2000;26:357-62.
13. Voogd A, Nielsen M, Peterse J, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001;19:1688-97.
14. Rosen P, Groshen S, Saigo P, KinneD, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median followup of 18 years. J Clin Oncol 1989;7:1239-51.
15. de Mascarel I, Bonichon F,Durand M, Mauriac L,MacGrogan G, Soubeyran I, et al. Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. Eur J Cancer 1998;34:58-65.
16. Lindley R, Bulman A, Parsons P, Phillips R, Henry K, Ellis H. Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy. Surgery 1989;105:13-20.
17. Holland R, Connolly J, Gelman R, Mravunac M, Hendriks J, Verbeek A, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-18.
18. Satake H, Shimamoto K, Sawaki A, Niimi R, Ando Y, Ishiguchi T, et al. Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Eur Radiol 2000;10:1726-32.
19. Volpi A, Nanni O, De Poalo F, Granato A, Mangia A, Monti F, et al. HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer. J Clin Oncol 2003;21:2708-12.
20. American Cancer Society (ACS)/National Comprehensive Cancer Network (NCCN). Breast Cancer: Treatment Guidelines for Patients, version VIII. ACS/NCCN; 2006.
21. Lamb P, Perry N, Vinnicombe S, Wells C. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol 2000;55:40-4.
22. Thurfjell M, Lindgren A, Thurfjell E. Nonpalpable breast cancer: mammographic appearance as predictor of histologic type. Radiology 2002;222:165-70.
23. Gajdos C, Tartter P, Bleiweiss I, Hermann G, de Csepel J, Estabrook A, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg 2002;235:246-51.
24. Stomper P, Geradts J, Edge S, Levine E. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol 2003;181:1679-84.
25. Tabar L, Tony CH, Amy YM, Tot T, Tung T, Chen L, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer 2004;101:1745-59.
26. Rotstein A, Neerhut P. Ultrasound characteristics of histologically proven grade 3 invasive ductal breast carcinoma. Australas Radiol 2005;49:476-9.
27. Evans A, Pinder S, James J, Ellis I, Cornford E. Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer? AJR Am J Roentgenol 2006;187:1377-80.
28. Bassett LW, Berg WA, Feig SA. Breast Imaging Reporting and Data System, BI-RADS: Mammography. 4th edn. Reston, VA: American College of Radiology, 2003.
29. Mendelson EB, Baum JK, Berg WA, Merritt CRB, Rubin E. Breast Imaging Reporting and Data. System, BI-RADS: Ultrasound. Reston, VA: American College of Radiology, 2003.
30. Reiner A, Reiner G, Spona J, Schemper M, Holzner J. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis. Cancer 1988;61:1149-54.
31. Oken S, Mercado C, Memeo L, Hibshoosh H. Invasive ductal carcinoma with fibrotic focus: mammographic and sonographic findings with histopathologic correlation. AJR Am J Roentgenol 2005;185:490-4.
32. Orel S, Mendonca M, Reynolds C, Schnall M, Solin L, Sullivan D. MR imaging of ductal carcinoma in situ. Radiology 1997;202:413-20.
33. Gilles R, Zafrani B, Guinebretiere J, Meunier M, Lucidarme O, Tardivon A, et al. Ductal carcinoma in situ: MR imaging- histopathologic correlation. Radiology 1995;196:415-19.
34. Berg W, Gilbreath P. Multicentric and multifocal cancer: whole-breast US in preoperative evaluation. Radiology 2000;214:59-66.
35. Thomson T, Hayes M, Spinelli J, Hilland E, Sawrenko C, Phillips D, et al. HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol 2001;14:1079-86.